2018
DOI: 10.1038/s41594-018-0049-1
|View full text |Cite
|
Sign up to set email alerts
|

Structural basis of small-molecule inhibition of human multidrug transporter ABCG2

Abstract: ABCG2 is an ATP-binding cassette (ABC) transporter that protects tissues against xenobiotics, affects the pharmacokinetics of drugs and contributes to multidrug resistance. Although many inhibitors and modulators of ABCG2 have been developed, understanding their structure-activity relationship requires high-resolution structural insight. Here, we present cryo-EM structures of human ABCG2 bound to synthetic derivatives of the fumitremorgin C-related inhibitor Ko143 or the multidrug resistance modulator tariquid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

24
382
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 288 publications
(406 citation statements)
references
References 66 publications
24
382
0
Order By: Relevance
“…One method is to use lipid nanodiscs, where the membrane protein resides in a small patch of lipid bilayer encircled by an amphipathic scaffolding protein (Bayburt et al, 2002). The nanodisc method has been employed to study the anthrax toxin pore at 22-Å resolution (Katayama et al, 2010), TRPV1 ion channel in complex with ligands at 3-4 Å resolution (Gao et al, 2016), and other membrane proteins (Autzen et al, 2018;Bayburt et al, 2002;Chen et al, 2017;Dang et al, 2017;Gao et al, 2016;Jackson et al, 2018;Katayama et al, 2010;McGoldrick et al, 2018;Roh et al, 2018;Srivastava et al, 2018;Taylor et al, 2017). Another method, called "random spherically constrained" (RSC) single-particle cryo-EM, where the membrane protein is reconstituted into liposomes, was developed and employed to study the large conductance voltage-and calcium-activated potassium (BK) channels reconstituted into liposomes at 17-Å resolution (Wang and Sigworth, 2009).…”
Section: Introductionmentioning
confidence: 99%
“…One method is to use lipid nanodiscs, where the membrane protein resides in a small patch of lipid bilayer encircled by an amphipathic scaffolding protein (Bayburt et al, 2002). The nanodisc method has been employed to study the anthrax toxin pore at 22-Å resolution (Katayama et al, 2010), TRPV1 ion channel in complex with ligands at 3-4 Å resolution (Gao et al, 2016), and other membrane proteins (Autzen et al, 2018;Bayburt et al, 2002;Chen et al, 2017;Dang et al, 2017;Gao et al, 2016;Jackson et al, 2018;Katayama et al, 2010;McGoldrick et al, 2018;Roh et al, 2018;Srivastava et al, 2018;Taylor et al, 2017). Another method, called "random spherically constrained" (RSC) single-particle cryo-EM, where the membrane protein is reconstituted into liposomes, was developed and employed to study the large conductance voltage-and calcium-activated potassium (BK) channels reconstituted into liposomes at 17-Å resolution (Wang and Sigworth, 2009).…”
Section: Introductionmentioning
confidence: 99%
“…BCRP is a 72kDa half-transporter that is 655 amino acids in length. It has one N-terminal NBD and one C-terminal six-segment TMD (Allikmets et al, 1998;Taylor et al, 2017;Jackson et al, 2018). The half-transporter forms a homodimer through disulfide bond formation, an event required for efflux function (Henriksen et al, 2005;Wakabayashi et al, 2006;Khunweeraphong et al, 2017).…”
Section: Biochemical and Physiologic Characteristics Of Bcrpmentioning
confidence: 99%
“…As high levels of ABCG2 is 9 closely correlated with multi-drug resistance in cancer cells, numerous studies have 10 investigated the structural requirements for inhibition of this protein. The protein structure of 11 the ABCG2-FTC complex has recently been published (19). This shows that FTC binds into 12 the active site (competitive inhibition) and prevents conformational changes required for the 13 transportation activity (19).…”
Section: Hour Treatment Of Hepg2 Cellsmentioning
confidence: 99%
“…The protein structure of 11 the ABCG2-FTC complex has recently been published (19). This shows that FTC binds into 12 the active site (competitive inhibition) and prevents conformational changes required for the 13 transportation activity (19). It is presumed that this is the primary mode of inhibition due to 14 the fact that the most potent ABCG2 inhibitors contain several key structural similarities 15 which resemble the FTC molecule (20).…”
Section: Hour Treatment Of Hepg2 Cellsmentioning
confidence: 99%
See 1 more Smart Citation